nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—HSP90AA1—pineal body—ocular cancer	0.0375	0.341	CbGeAlD
Nedocromil—FPR1—lymphoid tissue—ocular cancer	0.0221	0.201	CbGeAlD
Nedocromil—HSP90AA1—eye—ocular cancer	0.0114	0.104	CbGeAlD
Nedocromil—HSP90AA1—retina—ocular cancer	0.0113	0.103	CbGeAlD
Nedocromil—HSP90AA1—epithelium—ocular cancer	0.0104	0.0947	CbGeAlD
Nedocromil—CYSLTR1—lymphoid tissue—ocular cancer	0.00925	0.0841	CbGeAlD
Nedocromil—HSP90AA1—lymphoid tissue—ocular cancer	0.00803	0.0729	CbGeAlD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—CDKN1A—ocular cancer	0.00244	0.00274	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—GNAQ—ocular cancer	0.00244	0.00274	CbGpPWpGaD
Nedocromil—CYSLTR1—Endothelins—AKT1—ocular cancer	0.00241	0.00271	CbGpPWpGaD
Nedocromil—HSP90AA1—Validated targets of C-MYC transcriptional activation—EP300—ocular cancer	0.00239	0.00268	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—GNA11—ocular cancer	0.00238	0.00267	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—E2F3—ocular cancer	0.00237	0.00266	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—RBBP4—ocular cancer	0.00237	0.00266	CbGpPWpGaD
Nedocromil—HSP90AA1—Regulation of Telomerase—MYC—ocular cancer	0.00235	0.00264	CbGpPWpGaD
Nedocromil—HSP90AA1—Regulation of Telomerase—TGFB1—ocular cancer	0.00234	0.00263	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—SAG—ocular cancer	0.00232	0.00261	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—EP300—ocular cancer	0.00232	0.00261	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—GNAQ—ocular cancer	0.00229	0.00257	CbGpPWpGaD
Nedocromil—HSP90AA1—Integrin-linked kinase signaling—AKT1—ocular cancer	0.00226	0.00254	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—E2F3—ocular cancer	0.00226	0.00254	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CDC25A—ocular cancer	0.00225	0.00253	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—CCND3—ocular cancer	0.00223	0.00251	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—GNAQ—ocular cancer	0.00221	0.00249	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—TFDP1—ocular cancer	0.0022	0.00248	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—E2F3—ocular cancer	0.00218	0.00245	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—CCND3—ocular cancer	0.00216	0.00242	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TFDP1—ocular cancer	0.0021	0.00236	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PSPH—ocular cancer	0.00208	0.00234	CbGpPWpGaD
Nedocromil—HSP90AA1—Validated targets of C-MYC transcriptional activation—MYC—ocular cancer	0.00208	0.00234	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—GNA11—ocular cancer	0.00206	0.00231	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—E2F5—ocular cancer	0.00205	0.00231	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—CDKN2B—ocular cancer	0.00205	0.0023	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TFDP1—ocular cancer	0.00203	0.00228	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—E2F4—ocular cancer	0.00201	0.00226	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CCND3—ocular cancer	0.002	0.00224	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—RBL1—ocular cancer	0.00197	0.00222	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—GNAQ—ocular cancer	0.00191	0.00215	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—E2F1—ocular cancer	0.00188	0.00211	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—GNA11—ocular cancer	0.00187	0.0021	CbGpPWpGaD
Nedocromil—HSP90AA1—Corticotropin-releasing hormone—TGFB1—ocular cancer	0.00184	0.00207	CbGpPWpGaD
Nedocromil—HSP90AA1—G2/M Transition—EP300—ocular cancer	0.00179	0.00202	CbGpPWpGaD
Nedocromil—HSP90AA1—Mitotic G2-G2/M phases—EP300—ocular cancer	0.00177	0.00199	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—GNAQ—ocular cancer	0.00174	0.00195	CbGpPWpGaD
Nedocromil—HSP90AA1—Integrins in angiogenesis—AKT1—ocular cancer	0.00173	0.00194	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—E2F3—ocular cancer	0.00171	0.00192	CbGpPWpGaD
Nedocromil—HSP90AA1—Validated targets of C-MYC transcriptional activation—TP53—ocular cancer	0.00171	0.00192	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—MDM2—ocular cancer	0.00167	0.00188	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MAML2—ocular cancer	0.00167	0.00187	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—CDK6—ocular cancer	0.00166	0.00187	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—TP53—ocular cancer	0.00166	0.00186	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—SAG—ocular cancer	0.00165	0.00185	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—ocular cancer	0.00163	0.00183	CbGpPWpGaD
Nedocromil—HSP90AA1—Regulation of Telomerase—AKT1—ocular cancer	0.00163	0.00183	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—CDK2—ocular cancer	0.00162	0.00182	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MAML2—ocular cancer	0.00161	0.00181	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SAG—ocular cancer	0.00161	0.00181	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TFDP1—ocular cancer	0.00159	0.00179	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—MDM2—ocular cancer	0.00153	0.00172	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—CDK4—ocular cancer	0.00153	0.00172	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—CDKN1B—ocular cancer	0.00152	0.00171	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CDK6—ocular cancer	0.00149	0.00167	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.00147	0.00166	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—E2F5—ocular cancer	0.00146	0.00164	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—GNA11—ocular cancer	0.00146	0.00163	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—HRAS—ocular cancer	0.00145	0.00163	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—CCND2—ocular cancer	0.00143	0.00161	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.00143	0.00161	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—E2F4—ocular cancer	0.00143	0.00161	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—GNA11—ocular cancer	0.00142	0.0016	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—E2F5—ocular cancer	0.00142	0.0016	CbGpPWpGaD
Nedocromil—HSP90AA1—EPH-Ephrin signaling—HRAS—ocular cancer	0.00142	0.0016	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—CDKN1A—ocular cancer	0.00141	0.00158	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—GNA11—ocular cancer	0.00141	0.00158	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—RBL1—ocular cancer	0.0014	0.00158	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—RPL39—ocular cancer	0.0014	0.00158	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—CDKN1B—ocular cancer	0.0014	0.00157	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—AKT1—ocular cancer	0.0014	0.00157	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—E2F4—ocular cancer	0.00139	0.00157	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—RBL1—ocular cancer	0.00137	0.00154	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—GNAQ—ocular cancer	0.00135	0.00152	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—RB1—ocular cancer	0.00133	0.0015	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—GNAQ—ocular cancer	0.00132	0.00149	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—GNAQ—ocular cancer	0.00131	0.00147	CbGpPWpGaD
Nedocromil—HSP90AA1—Influenza Infection—TGFB1—ocular cancer	0.00131	0.00147	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—GNA11—ocular cancer	0.00129	0.00145	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—CDKN1A—ocular cancer	0.00129	0.00145	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.00128	0.00144	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—HRAS—ocular cancer	0.00128	0.00144	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CCND2—ocular cancer	0.00128	0.00144	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—HDAC1—ocular cancer	0.00128	0.00144	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—AKT1—ocular cancer	0.00128	0.00144	CbGpPWpGaD
Nedocromil—HSP90AA1—Corticotropin-releasing hormone—AKT1—ocular cancer	0.00128	0.00144	CbGpPWpGaD
Nedocromil—HSP90AA1—NRF2 pathway—TGFB1—ocular cancer	0.00127	0.00143	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MAML2—ocular cancer	0.00126	0.00142	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—HDAC1—ocular cancer	0.00122	0.00137	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—HRAS—ocular cancer	0.00121	0.00136	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—GNAQ—ocular cancer	0.0012	0.00135	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—E2F3—ocular cancer	0.00119	0.00133	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—E2F1—ocular cancer	0.00118	0.00132	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—HDAC1—ocular cancer	0.00118	0.00132	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SAG—ocular cancer	0.00115	0.0013	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CDKN2B—ocular cancer	0.00115	0.00129	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—MDM2—ocular cancer	0.00113	0.00128	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—AKT1—ocular cancer	0.00113	0.00127	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—TFDP1—ocular cancer	0.00113	0.00127	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TFDP1—ocular cancer	0.0011	0.00124	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—GNA11—ocular cancer	0.0011	0.00124	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CDKN2B—ocular cancer	0.00109	0.00123	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—AKT1—ocular cancer	0.00107	0.0012	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CDKN2B—ocular cancer	0.00106	0.00119	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—E2F1—ocular cancer	0.00105	0.00118	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—CDKN1B—ocular cancer	0.00104	0.00116	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—GNAQ—ocular cancer	0.00103	0.00115	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.00102	0.00115	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—E2F5—ocular cancer	0.00102	0.00115	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—CDK2—ocular cancer	0.00102	0.00114	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—E2F1—ocular cancer	0.001	0.00113	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—E2F4—ocular cancer	0.001	0.00113	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—RBL1—ocular cancer	0.000982	0.0011	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—E2F1—ocular cancer	0.000969	0.00109	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—CDK4—ocular cancer	0.00096	0.00108	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—CDKN1A—ocular cancer	0.000956	0.00107	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—CDK4—ocular cancer	0.000927	0.00104	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—HDAC1—ocular cancer	0.000924	0.00104	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—HRAS—ocular cancer	0.000916	0.00103	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—EP300—ocular cancer	0.00091	0.00102	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CDK2—ocular cancer	0.000908	0.00102	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MAML2—ocular cancer	0.000898	0.00101	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MAML2—ocular cancer	0.000876	0.000984	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CDK4—ocular cancer	0.000858	0.000965	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—E2F3—ocular cancer	0.000851	0.000957	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—HRAS—ocular cancer	0.000842	0.000946	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—RB1—ocular cancer	0.000835	0.000938	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CDKN2B—ocular cancer	0.000828	0.000931	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—AKT1—ocular cancer	0.000809	0.000909	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TFDP1—ocular cancer	0.000792	0.000889	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—GNA11—ocular cancer	0.000764	0.000859	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—E2F1—ocular cancer	0.00076	0.000854	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—RB1—ocular cancer	0.000746	0.000839	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—AKT1—ocular cancer	0.000744	0.000836	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—GNAQ—ocular cancer	0.000711	0.000798	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—HDAC1—ocular cancer	0.000657	0.000738	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GNA11—ocular cancer	0.000656	0.000737	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—TP53—ocular cancer	0.000651	0.000732	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.00065	0.00073	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HDAC1—ocular cancer	0.000641	0.00072	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—MDM2—ocular cancer	0.000636	0.000715	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MAML2—ocular cancer	0.000629	0.000707	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—CCND1—ocular cancer	0.00062	0.000697	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GNAQ—ocular cancer	0.00061	0.000685	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—MDM2—ocular cancer	0.000607	0.000682	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MDM2—ocular cancer	0.000606	0.000681	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.0006	0.000674	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CDKN2B—ocular cancer	0.000589	0.000661	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MDM2—ocular cancer	0.000586	0.000658	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CDKN1B—ocular cancer	0.000581	0.000653	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CDKN2B—ocular cancer	0.000574	0.000645	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—EP300—ocular cancer	0.000571	0.000641	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—HRAS—ocular cancer	0.000563	0.000633	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CCND1—ocular cancer	0.000554	0.000623	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CDKN1B—ocular cancer	0.000554	0.000623	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CDKN1B—ocular cancer	0.000554	0.000622	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—EP300—ocular cancer	0.000551	0.000619	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GNA11—ocular cancer	0.000549	0.000616	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—AKT1—ocular cancer	0.000548	0.000615	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—HRAS—ocular cancer	0.000544	0.000611	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CDKN1A—ocular cancer	0.000536	0.000603	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CDKN1B—ocular cancer	0.000535	0.000601	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—AKT1—ocular cancer	0.000529	0.000594	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—HRAS—ocular cancer	0.000529	0.000594	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CCND1—ocular cancer	0.000528	0.000593	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—E2F1—ocular cancer	0.000527	0.000592	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CDKN1A—ocular cancer	0.000512	0.000575	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CDKN1A—ocular cancer	0.000511	0.000574	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—EP300—ocular cancer	0.00051	0.000573	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GNAQ—ocular cancer	0.00051	0.000573	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CCND1—ocular cancer	0.00051	0.000573	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—AKT1—ocular cancer	0.000497	0.000559	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—MYC—ocular cancer	0.000497	0.000559	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CDKN1A—ocular cancer	0.000493	0.000554	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—EP300—ocular cancer	0.000487	0.000547	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—EP300—ocular cancer	0.000486	0.000546	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—AKT1—ocular cancer	0.00048	0.00054	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TGFB1—ocular cancer	0.000479	0.000538	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—EP300—ocular cancer	0.000469	0.000528	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HDAC1—ocular cancer	0.00046	0.000517	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MDM2—ocular cancer	0.000459	0.000516	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—MYC—ocular cancer	0.000445	0.0005	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—HRAS—ocular cancer	0.000427	0.00048	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MYC—ocular cancer	0.000424	0.000476	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TGFB1—ocular cancer	0.000423	0.000475	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CDKN1B—ocular cancer	0.00042	0.000471	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—AKT1—ocular cancer	0.000415	0.000466	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CDKN2B—ocular cancer	0.000412	0.000463	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MYC—ocular cancer	0.000409	0.00046	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TGFB1—ocular cancer	0.000408	0.000459	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCND1—ocular cancer	0.0004	0.00045	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CDKN1A—ocular cancer	0.000387	0.000435	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—E2F1—ocular cancer	0.000378	0.000425	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—HRAS—ocular cancer	0.000377	0.000424	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—AKT1—ocular cancer	0.000377	0.000423	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—EP300—ocular cancer	0.000368	0.000414	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—TP53—ocular cancer	0.000365	0.00041	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—MDM2—ocular cancer	0.000354	0.000397	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TP53—ocular cancer	0.000348	0.000391	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TP53—ocular cancer	0.000336	0.000378	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—HRAS—ocular cancer	0.000333	0.000374	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—AKT1—ocular cancer	0.000333	0.000374	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—HRAS—ocular cancer	0.000333	0.000374	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MDM2—ocular cancer	0.000326	0.000367	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CDKN1B—ocular cancer	0.000323	0.000363	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—HRAS—ocular cancer	0.000321	0.000361	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MYC—ocular cancer	0.000321	0.000361	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TGFB1—ocular cancer	0.00032	0.00036	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MDM2—ocular cancer	0.000318	0.000358	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CDKN1B—ocular cancer	0.000298	0.000335	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CDKN1A—ocular cancer	0.000298	0.000335	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—HRAS—ocular cancer	0.000296	0.000332	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—AKT1—ocular cancer	0.000294	0.000331	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—AKT1—ocular cancer	0.000294	0.00033	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CDKN1B—ocular cancer	0.000291	0.000327	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—AKT1—ocular cancer	0.000288	0.000323	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—AKT1—ocular cancer	0.000284	0.000319	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—EP300—ocular cancer	0.000284	0.000319	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCND1—ocular cancer	0.000277	0.000312	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CDKN1A—ocular cancer	0.000275	0.000309	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CDKN1A—ocular cancer	0.000268	0.000302	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TP53—ocular cancer	0.000264	0.000296	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—EP300—ocular cancer	0.000262	0.000294	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—AKT1—ocular cancer	0.000261	0.000294	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—EP300—ocular cancer	0.000255	0.000287	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—HRAS—ocular cancer	0.000252	0.000283	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MDM2—ocular cancer	0.000229	0.000257	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MYC—ocular cancer	0.000228	0.000256	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—TGFB1—ocular cancer	0.000228	0.000256	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—AKT1—ocular cancer	0.000223	0.00025	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MYC—ocular cancer	0.000223	0.00025	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TGFB1—ocular cancer	0.000222	0.000249	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—EP300—ocular cancer	0.000219	0.000246	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CDKN1B—ocular cancer	0.000209	0.000235	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCND1—ocular cancer	0.000199	0.000224	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—HRAS—ocular cancer	0.000194	0.000218	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CDKN1A—ocular cancer	0.000193	0.000216	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—EP300—ocular cancer	0.000183	0.000206	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TP53—ocular cancer	0.000183	0.000205	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—HRAS—ocular cancer	0.000179	0.000201	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HRAS—ocular cancer	0.000175	0.000196	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—AKT1—ocular cancer	0.000171	0.000193	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MYC—ocular cancer	0.00016	0.000179	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TGFB1—ocular cancer	0.000159	0.000179	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—AKT1—ocular cancer	0.000158	0.000178	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AKT1—ocular cancer	0.000154	0.000173	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—AKT1—ocular cancer	0.000132	0.000149	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TP53—ocular cancer	0.000131	0.000147	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HRAS—ocular cancer	0.000125	0.000141	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AKT1—ocular cancer	0.000111	0.000124	CbGpPWpGaD
